过度表达RBCK1与免疫细胞透和肝细胞癌的不良预后有关
Jingjing Yu1,2, Tianming Liu2, Mingjiang Liu1,3
1The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Aging
|January 12, 2024
概括
在许多癌症中,E3泛基因酶RBCK1的升高调节,与患者预后不佳相关. RBCK1影响蛋白调节和免疫细胞透,抑制细胞亡和入侵肝癌.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- RBCK1 (也称为RNF123) 是一种E3泛基因酶,涉及各种疾病.
- 它在泛癌症中的作用,特别是关于免疫细胞透和患者预后,仍然在很大程度上未被描述.
研究的目的:
- 为了研究RBCK1在不同癌症类型中的表达模式.
- 探索RBCK1表达和患者预后之间的关联.
- 阐明RBCK1在癌症中的功能机制,包括它与免疫细胞的相互作用.
主要方法:
- 在泛癌数据集中分析RBCK1表达.
- 预测相关性研究.预测相关性研究.
- 基因变异分析.
- 蛋白质与蛋白质相互作用网络分析.
- 在肝癌中免疫细胞透分析.
- 在肝细胞癌 (HCC) 中的实验验证.
主要成果:
- 在许多恶性瘤中,RBCK1的表达显著上调.
- 较高的RBCK1表达与较差的患者结果相关.
- RBCK1调节核蛋白表达,核糖体生物发生和氨基酸降解 (氨酸,氨酸,异氨酸).
- 在RBCK1中错误的突变与不良预后有关.
- RBCK1与多种蛋白质相互作用,包括RNRPB,MCRS1,TRIB3,MKKS和ARPC3.
- 在肝癌中,RBCK1表达与T细胞和巨细胞正相关,与中性粒细胞,NK细胞和DC细胞负相关.
- 在实验中,RBCK1抑制了HCC细胞的亡和入侵.
结论:
- RBCK1是多种癌症的关键调节者,影响预后和免疫微环境.
- RBCK1在肝细胞癌的发病和进展中发挥着重要作用.
- 向RBCK1可能为各种恶性瘤提供治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
相关概念视频
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K